The Effect of Nebulized Furosemide in Patients with Acute Cardiogenic Pulmonary Edema: A Randomized Clinical Trial
Background and Objectives: Furosemide is one of the elements of drug therapy for cardiogenic pulmonary edema, but its systemic administration is associated with complications, such as hypotension, renal damage, and decreased serum potassium. Inhalation administration is a new route, which does not h...
Main Authors: | Babak Mahshidfar, Reza Mosaddegh, Mehdi Rezaee, AmirSadegh Alimardani |
---|---|
Format: | Article |
Language: | fas |
Published: |
Qom University of Medical Sciences
2018-12-01
|
Series: | Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum |
Subjects: | |
Online Access: | http://journal.muq.ac.ir/browse.php?a_code=A-10-1379-1&slc_lang=en&sid=1 |
Similar Items
-
Intravenous furosemide vs nebulized furosemide in patients with pulmonary edema: A randomized controlled trial
by: Hasan Barzegari, et al.
Published: (2021-03-01) -
Effect of furosemide in the treatment of high-altitude pulmonary edema
by: Dava Tenzing, et al.
Published: (2024-03-01) -
The emerging role of nebulization for maintenance treatment of chronic obstructive pulmonary disease at home
by: Deepak Talwar, et al.
Published: (2021-01-01) -
Effects of postoperative nebulized furosemide and budesonide on postoperative sore throat in patients undergoing maxillofacial surgery: A randomized controlled trial
by: Jie An, et al.
Published: (2023-03-01) -
Pulmonary Edema in COVID-19 Treated with Furosemide and Negative Fluid Balance (NEGBAL): A Different and Promising Approach
by: Jose L. Francisco Santos, et al.
Published: (2021-11-01)